Phase 3

April 21, 2022
pharmacovigilance services
April 21, 2022

Scaling up to address safety challenges for an Oncology product

APCER life sciences through its oncology expertise helped the pharma …
Do you like it?
View more
March 8, 2021
March 8, 2021

Enabling compliance through strong PSMF management & QPPV oversight

APCER helped a leading generics company to streamline its PV …
Do you like it?
View more
March 8, 2021
March 8, 2021

Established a unified, global PV system for a pharma company after multiple M&A

We helped a large pharmaceutical company successfully transition its pharmacovigilance …
Do you like it?
View more
March 8, 2021
end to end pharmacovigilance
March 8, 2021

Enabling global expansion by establishing an integrated PV system

APCER helped a global pharmaceutical company in establishing a collaborative …
Do you like it?
View more
March 8, 2021
March 8, 2021

Efficient Risk Management Support for Marketing Authorization Applications in LATAM Region for a Leading Pharma Company

APCER Life Sciences supported a leading generic pharma company with …
Do you like it?
View more
March 8, 2021
March 8, 2021

GCP Audits in EU requiring local language competency for a biopharma company

We helped a biopharma company to set up end-to-end Quality …
Do you like it?
View more
March 8, 2021
March 8, 2021

Bridging the gaps and inconsistencies within CT program through an expert overlay of medical monitors

Our medical monitoring team with experience and expertise in early …
Do you like it?
View more